Case Studies

Market access strategy / Systematic literature review / Cost-effective model / Value proposition / Global reimbursement dossier / Objection handler / Pharma

Delivering on global market access strategy, evidence generation and communication objectives

Our client’s global market access team were looking for a consultancy who could support them from strategy to implementation. As the client was in the early stages of developing a new product, they first wanted to understand the challenges and opportunities that their new treatment would face when launching in different markets. Subsequently, the client wanted support with evidence generation and the development of their value communication materials.

View case study
Exploring the US market landscape
US market access strategy / Market research / Digital health technology / Medtech

Exploring the US market landscape and developing strategy for a digital health technology

Our client was looking to explore the routes to reimbursement in the US for their product in early stages of development. The product consisted of an already Food and Drug Administration (FDA) approved class I medical device and a new cloud-based mobile app. The client was looking to understand the conventional route to reimbursement for the combined product, as well as other applicable reimbursement and patient access schemes (PASs), including the evidence requirements and formal mechanisms for application and review.

View Case Study
US market access strategy / Health economics / AMCP dossier / Budget impact model / Local market adaptation / Pharma

Building a budget impact model for AMCP submission in the US

Our client was launching a new treatment in the US. They were looking for a health economics consultancy with knowledge of the US market to develop a budget impact model that would resonate with US payers and generate data suitable for Academy of Managed Care Pharmacy (AMCP) formulary submission.

View case study
Exploring funding and reimbursement routes for digital health technologies across EU4, UK and US
Reimbursement strategy / Funding strategy / Product launch / Evidence strategy / Stakeholder mapping / Digital health technology

Exploring funding and reimbursement routes for digital health technologies across EU4, UK and US

Our client had several innovative digital health solutions in their pipeline and was looking to understand how to obtain funding in major European and US markets. The client was keen to explore both conventional reimbursement routes for digital health technologies across these markets, as well as any alternative patient access, funding, evidence development and early access schemes available.

View Case Study
NHS variation in care
NHS insights / White Paper / Advisory board / Evidence strategy / Health policy

Delivering a White Paper to highlight national variation in care, and propose solutions for improving care across the NHS

Our client sought to explore the national variation in care for their target disease area and present the research in a White Paper. The publication needed to highlight the challenges and potential solutions faced by the health service, largely around the variation in current care across the country.

View case study
Market access strategy / Evidence strategy / Pricing strategy / HTA payer insights / Pharma

Gaining global payer insights to inform clinical trial design, price and market access strategy

Our client had a biologic product in clinical development for several different dermatological conditions. In preparation for their Phase 3 trial for the second planned indication, they sought input from payers into key elements of the target product profile (TPP).

View Case Study
UK Market access strategy / Market research / Stakeholder mapping / NHS insights / Diagnostic / Medical devices

Understanding the diagnostic market access landscape in the UK

Our client’s team were looking for a consultancy to support them in understanding the diagnostics market access landscape across the UK. They were seeking to identify and explore current and future opportunities and routes to market within the NHS and how to optimise these…

View case study
Market access strategy / Evidence strategy / Market research / Targeted literature review / Rare disease / Orphan drugs / Pharma

Researching market access pathways, reimbursement requirements and implications of orphan drug designation for a rare disease product

With a rare disease therapy in early development, our client wanted to gain a deeper understanding of the market access routes available and the evidence requirements for key reimbursement pathways.

View Case Study
Value communication / Budget impact model / Value proposition / Price comparison / Digital toolkit / Web companion

Giving healthcare customers a true picture of budget impact

Typically, budget impact models enable comparison between products by using publicly available ‘list’ prices. However, both NHS and industry are aware that these do not reflect the actual cost of the treatments, as list prices do not account for the discounts negotiated by healthcare providers. Our client was looking to enable their customers to compare the net price of products, including these confidential discounts, to give a true picture of the value of their product.

View case study
Developing a digital toolkit to demonstrate the value of a pharmaceutical technology to secondary care providers
Value communication / Budget impact model / Value proposition / Digital toolkit / NHS insights / iPad App / CRM integration / KAM training / Pharma

Developing a digital toolkit to demonstrate the value of a pharmaceutical technology to secondary care providers

Our client was looking to develop a digital value communication tool for their Key Account Managers (KAMs) to use with secondary care decision-makers to demonstrate the clinical and economic value of bringing prescribing practices in line with new NICE treatment guidelines that included a recommendation for use of their product.

View Case Study
Reviewing HTA decisions in key markets across the globe
HTA strategy / Evidence strategy / Market research / Data analysis / Rare disease / Pharma

Reviewing HTA decisions in key markets across the globe

With a gene therapy for a rare disease in early development, the client was looking to understand how previous therapies in the same disease area have approached their health technology assessment (HTA) submissions, as well as the key challenges and critique previously received by HTA agencies in key markets across the globe.

View case study
Understanding changing perceptions of value in the NHS
Understanding NHS customers / NHS payer insights / Advisory board / NHS insights

Understanding changing perceptions of value in the NHS

The client was looking to help a newly formed team to improve their understanding of how value is perceived across the NHS by different key stakeholders. Their overall aim was to understand how the team could deliver value for the NHS in new ways whilst better supporting clinicians in the implementation of clinical guidelines.

View Case Study
European payer insights / Market access strategy / Advisory board / Pricing strategy / Pharma

Gaining European payer insights with an advisory board

Our Client was now looking to gain European payer insights for potential future indications across the cardiovascular disease space. Our Client wanted to understand the challenges and opportunities that their new treatment would face when launching in different markets.

View case study
Value communication / Cost-consequence model / Health economics / Digital toolkit / iPad App / Local market adaptation

Optimising visualisation and communication in an app-based Cost-Consequence Model

Our client had a cost-consequence model in Excel that had been developed by their internal global market access team. They were seeking an agency to re-build this model as an interactive digital app for use in the field.

View Case Study
Value communication / Data visualisation dashboard / Real-world data / Connected Insights / Veeva-compatible

Using real-world data to build a case for change

Our client was looking for a visually compelling way to enable their field teams to present health data on relevant health economies to NHS decision-makers.

View case study
Challenging European policy proposals with an evidence-driven submission on behalf of a cross-industry consortium
Health policy / Pharma/ Medical devices / Above brand/ Europe/ Targeted literature review/ Expert opinion/ Evidence submission

Challenging European policy proposals with an evidence-driven submission on behalf of a cross-industry consortium

We were approached by a consortium of global pharmaceutical and medical device companies who were concerned about proposed new European legislation that would impact the group’s products and detrimentally impact patient care.

View case study
Communicating value with a suite of visually impactful materials connected via a digital platform
Global value dossier (GVD) / Value proposition / Systematic literature review / Global evidence / Data analysis / Digital GVD Platform / Medical device

Communicating value with a suite of visually impactful materials connected via a digital platform

To support payer engagement and reimbursement activities, our client was looking for a partner to develop a suite of value communication materials for their medical device.

View case study
Testimonials

Read our testimonials

Click to read our testimonials

Start your project today

Ready to get your project started, get in touch today to discuss your business goals.

    Keep me up to date with the latest news and events.